Printer Friendly
The Free Library
14,558,366 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: The Pulmonary Drug Delivery Technologies - Global Strategic Business Report Profiles 55 Companies Including Many Key and Niche Players Worldwide Such as 3M Pharmaceuticals and GlaxoSmithKline.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c62995) has announced the addition of Pulmonary pulmonary /pul·mo·nary/ (pool´mo-nar?e)
1. pertaining to the lungs.

2. pertaining to the pulmonary artery.


pul·mo·nar·y
adj.
Of, relating to, or affecting the lungs.
 Drug Delivery Technologies - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in Millions of USD USD

In currencies, this is the abbreviation for the U.S. Dollar.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
. The specific product segments analyzed an·a·lyze  
tr.v. an·a·lyzed, an·a·lyz·ing, an·a·lyz·es
1. To examine methodically by separating into parts and studying their interrelations.

2. Chemistry To make a chemical analysis of.

3.
 are Metered Dose Inhalers (MDIs), Dry Powder Inhalers The Dry Powder Inhaler is generally a proprietary device to deliver medications for the treatment or maintenance management of respiratory diseases and conditions. These conditions or diseases may include Asthma, Bronchitis, Emphysema, COPD and Diabetes.  (DPIs) and Nebulizers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies.  and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 55 companies including many key and niche players worldwide such as 3M Pharmaceuticals, 3M Drug Delivery Systems Division, Alkermes Inc., Aradigm, AstraZeneca Plc, Baxter Healthcare Corporation, Bespak Europe Ltd, Chiesi Farmaceutici SpA, Dey L.P., GlaxoSmithKline, Inyx Inc., LAB International Inc., Nektar Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, Oriel Therapeutics Inc., Sepracor Inc., SkyePharma Plc, Vectura, and Ventaira Pharmaceuticals Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL URL
 in full Uniform Resource Locator

Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program.
 research and reported select online sources.

Content Outline:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

1. Market Dynamics

2. Trends and Issues

3. Growth Drivers

4. Product Overview

5. An Overview of Pulmonary Conditions and Therapies

6. Regulatory Environment

7. Product Developments

8. Product Innovations/Introductions

9. Recent Industry Activity

10. Industry Activity in the Recent Past

11. Focus on Select Key Players

12. Global Market Perspective

III. MARKET

IV. COMPETITION

Companies Mentioned:

- 3M Company (USA)

- 3M Drug Delivery Systems (USA)

- 3M Health Care Ltd (UK)

- Accentia Biopharmaceuticals (USA)

- Alkermes, Inc (USA)

- Acusphere, Inc (USA)

- AerovectRx Corporation (USA)

- AirPharma LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 (USA)

- Alliance Pharmaceutical Corporation (USA)

- A-M A-M Alternating Maximization (algorithm)  Systems, Inc(USA)

- Applera Corporation (USA)

- Aradigm Corporation (USA)

- AstraZeneca PLC (UK)

- Bang & Olufsen Medicom A/S (Denmark)

- Baxter Healthcare Corporation (USA)

- Boehringer Ingelheim GmbH (Germany)

- Cardinal Health <includeonly></includeonly>

Cardinal Health (NYSE: CAH) is a premier, global healthcare company dedicated to making healthcare safer and more productive. Overview
Headquartered in Dublin, Ohio, Cardinal Health, Inc.
, Inc (USA)

- Chiesi Farmaceutici SpA (Italy)

- CyDex, Inc (USA)

- Dey LP (USA)

- Elan (Emulated LAN) A virtual LAN in the ATM world. See LANE and virtual LAN.

Elan - ["Top-down Programming with Elan", C.H.A. Koster, Ellis Horwood 1987].
 Corporation Plc (Ireland)

- Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States.  (USA)

- Evit Labs Inc (USA)

- Exaeris, Inc (USA)

- Generex Biotechnology Corporation (Canada)

- GlaxoSmithKline PLC (UK)

- Graceway Pharmaceuticals LLC (USA)

- Innovata PLC (UK)

- InterMune Pharmaceuticals, Inc (USA)

- Inyx Pharma Limited (UK)

- Inyx, Inc (USA)

- Lab International, Inc (USA)

- Map Pharmaceuticals, Inc (USA)

- Medel SpA (Italy)

- Medical Industries of America, Inc (USA)

- Medifiq (Finland)

- Monaghan Medical Corporation (USA)

- Nastech Pharmaceutical Company Inc (USA)

- Nektar Therapeutics (USA)

- Nipro Pharma Corporation (Japan)

- Novartis Pharma Switzerland AG (Switzerland)

- OctoPlus NV (The Netherlands)

- Omron Healthcare Co, Ltd (Japan)

- Omron Healthcare Europe BV (The Netherlands)

- Omron Healthcare, Inc (USA)

- Oriel Therapeutics, Inc (USA)

- PARI Respiratory Equipment, Inc (USA)

- Pfizer, Inc (USA)

- Respirics, Inc (USA)

- Schering-Plough Corporation (USA)

- Sepracor, Inc (USA)

- SkyePharma PLC (UK)

- Sonus Pharmaceuticals, Inc (USA)

- Teikoku Seiyaku Co, Ltd (Japan)

- Teamm Pharmaceuticals, Inc (USA)

- TransPharma Medical Limited (Israel)

- Trinity Pharmaceuticals (UK)

- Trudell Medical International (Canada)

- Valois Pharmaceutical Division (France)

- Vectura Group PLC (UK)

- Ventaira Pharmaceuticals, Inc (USA)

- West Pharmaceutical Services, Inc (USA)

- XstalBio Ltd (UK)

For more information visit http://www.researchandmarkets.com/reports/c62995
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 17, 2007
Words:492
Previous Article:Gain an Insight into the Evolution of the Indian Cosmetics Sector.
Next Article:Research and Markets: Keolis, SNCF and Veolia Environnement S.A. Are among the Leading Companies Operating in the Railroad Industry in France.
Topics:



Related Articles
A small bright star: indexed universal life insurance was the fastest-growing product line in the individual life insurance galaxy last year, and...
Axa Distributors LLC.(Tech Bytes)
Market response: midyear reinsurance renewals show signs of softening as companies look for fresh ways to deploy excess capital.(Reinsurance/Capital...
Take three packets of information on pharmaceutical products.(The Exchange)
Learn about the Intranasal Drug Delivery Market in the US - Forecasts to 2010.
EuroBiO 2007 in Lille, France - Sept 26th-28th.
New Report Gives Forecasts to 2010 for the Global Botulinum Toxin Market.
Research and Markets: An Analysis of the Critical Components That Make up Dr Reddys.(Company overview)
Encorium Group, Inc. Announces $4.0 Million of Additional New Business Contracts.
Research and Markets: An Analysis of the US Market for Intranasal Drug Delivery.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles